Outgoing links
- Acanthosis
- Acitretin
- Acrodermatitis continua suppurativa
- Adalimumab
- Adhesion molecules
- AhR receptor
- Alefacept
- Aloe vera
- Aloin
- Antimalarials
- antimicrobial peptides
- Apremilast
- Atopic dermatitis (overview)
- Balneo-phototherapy
- B-clear
- Bechterew's disease
- Berber
- Betamethasone
- Betamethasone valerate cream hydrophilic 0.025/0.05 or 0.1% (nrf 11.37.)
- Beta-receptor blockers
- Betulin
- Boswellia serrata Roxb.
- Brodalumab
- BSA
- Calcineurin inhibitors
- Calcipotriol
- Calcitriol
- Calcium antagonists
- Candle spot phenomenon
- CARD14 Gene
- Cathelicidins
- Ccl27
- CCL27 gene
- CCR10
- Celiac disease
- Certolizumab pegol
- Childhood psoriasis
- Ciclosporin a
- Climatotherapy
- Collagen type iv
- Coronary heart disease
- Defensin-like proteins
- Defensins
- Deucravacitinib
- Diltiazem
- Dithranol
- Dithranol ointment washable 0,05/0,1/0,25/0,5/1 or 2% without or with salicylic acid 2% (nrf 11.52.)
- Dithranol vaseline 0,05/0,1/0,25/0,5/1 or 2 % without or with salicylic acid 2 % (nrf 11.51.)
- Dupilumab
- Efalizumab
- Epidermal differentiation complex
- Epidermotropy
- Erythrodermia psoriatica
- Etanercept
- Frankincense
- Fumaric acid ester
- Galenos (galen)
- Glucocorticosteroids
- Glucocorticosteroids systemic
- Golimumab
- Guselkumab
- Guttate psoriasis
- Hebra, hans von
- HLA-B27
- HLA-Cw1
- HLA-Cw6
- Hydrotherapy
- Hypertension, isolated systolic
- Iga nephropathy
- Impetigo herpetiformis
- Indomethacin
- Inflammasome
- Infliximab
- Integrins
- Interleukin-17 cytokines
- Interleukin-2
- Interleukin-22
- Interleukin-23
- Interleukin-3
- Intertriginous psoriasis
- Interval therapy
- Inverted psoriasis
- Ixekizumab
- Janus kinase inhibitors
- Koebner heinrich
- Koebner phenomenon
- LCE3A gene
- LCE3B gene
- LCE3C gene
- Leflunomide
- Leprosy (overview)
- LFA-1
- Lithium
- Ll37
- Macrolide antibiotics
- Mahonia
- Mahoniae cortex
- Mahoniae radix
- Metabolic syndrome
- Metabolic syndrome
- Methotrexate
- Mometasone furoat
- Munro microabscess
- Mycophenolate mofetil
- NFKBIA Gene
- Non steroidal anti-inflammatory drugs
- Obesity
- Off-label use
- Order therapy
- Papillomatosis
- Parahyperkeratosis
- Pasi
- Peaking out phenomenon
- Phenomenon of the last cuticle
- Phosphodiesterase inhibitors
- Photodynamic therapy
- Phototherapy
- Pimecrolimus
- Pix lithanthracis
- Polymorphism
- Psoriasin
- Psoriasis anularis
- Psoriasis arthropathica
- Psoriasis capitis
- Psoriasis erythema anulare centrifugum-like
- Psoriasis follicularis
- Psoriasis of the nails
- Psoriasis palmaris et plantaris (overview)
- Psoriasis pustulosa
- Psoriasis seborrhoic type
- Psoriasis (Übersicht)
- Psoriasis vulgaris
- Psoriasis vulgaris chronic active plaque type
- Psoriasis vulgaris plaque type
- Psoriatic arthritis
- PSORS10
- PSORS11
- PSORS12
- PSORS13
- PSORS14
- PSORS15
- PSORS1C2 gene
- PSORS3
- PSORS4
- PSORS5
- PSORS6
- PSORS7
- PSORS8
- PSORS9
- Pustular psoriasis
- Pustular psoriasis palmaris et plantaris
- Pustulosis palmaris et plantaris
- Puva bath therapy
- Puva therapy
- Quality of life
- Quantiferon tb gold test
- Regional enteritis
- REL gene
- Repuva therapy
- Retinoids
- Rheumatoid arthritis and skin manifestations
- Risankizumab
- RNASE7 gene
- Roflumilast
- Salicylic acid
- Secukinumab
- Semaglutide
- Solar dermatitis
- Sulfasalazine
- Sup
- Tacalcitol
- Tacrolimus
- Tandem therapy
- Tapinarof
- Tazarotene
- Th17 lymphocyte
- Tildrakizumab
- Tnf-alpha antagonists
- Tofacitinib
- Triamcinolone acetonide cream hydrophilic 0,025/0,05/0,1% (nrf 11.38.)
- Triamcinolone acetonide cream, low water (according to gloor) (w/o)
- TYK2-gene
- Ustekinumab
- Uv irradiation
- Vegf
- Vitamin d3 analogues
- Willan, robert
- Witch hazel virginiana
- ZAP70 Gene
Back to article